Business Wire

STONEBRANCH

9.4.2024 15:01:34 CEST | Business Wire | Press release

Share
Stonebranch Unveils Comprehensive 2024 Global State of IT Automation Report

Stonebranch, a leading provider of service orchestration and automation solutions, today published the 2024 Global State of IT Automation Report: IT Automation and Orchestration Benchmarks for IT Ops, DevOps, CloudOps, and DataOps Teams, its third-annual benchmark study on the automation priorities, expectations, and challenges of IT professionals worldwide.

“We're pleased to release our Global State of IT Automation Report, now in its third year,” said Giuseppe Damiani, Stonebranch CEO. “This research offers a detailed analysis of current trends, challenges, and opportunities in IT automation and orchestration, providing valuable benchmarks for IT professionals worldwide. We're passionate about contributing to the IT industry's evolution and innovation, and we're dedicated to helping our customers realize their automation potential.”

Key Insights from the 2024 Global State of IT Automation Report

The 2024 Global State of IT Automation Report is based on a survey of IT automation professionals and executives, conducted by Censuswide between January 24 – February 5, 2024.

This year's report unveils critical insights into the evolving landscape of IT automation, offering a unique lens through which IT Ops, DevOps, CloudOps, and DataOps professionals can view the future of automation and orchestration technologies. Three notable emerging trends include:

  • Automation is Evolving into Orchestration: Driven by a desire to orchestrate across complex hybrid IT environments, 82% of respondents plan to replace legacy IT automation tools or add new automation tools to the mix.
  • Democratization of Automation Continues to Grow: 88% of respondents enable end-users across the business with self-service access to IT automation. Those who plan to add or replace IT automation tools with a more modern solution cited a desire to add self-service as the leading reason for change.
  • Companies Prefer a Mix of On-Prem and Cloud Environments: In only one year, hybrid IT usage has doubled from 34% to 68%. Organizations are deciding where to store data — either on-prem or cloud — on a case-by-case basis. This approach is efficient and flexible but poses a challenge when it comes to automating and orchestrating these environments.
  • Machine Learning Pipelines are Evolving and Growing in Importance: A significant 74% of respondents have already incorporated data and ML pipelines to operationalize their AI-driven initiatives. This is an indicator of many companies’ strong commitment to the pivotal role of AI in shaping their future success.

Peter Baljet, Stonebranch CTO, notes, “Our findings show that companies are adapting their IT automation and orchestration strategies to meet the specific challenges that come with cloud technologies. In the complex world of today’s hybrid IT environments, automation is crucial to enhance performance, secure systems, and control costs.”

To fully explore the research results:

  • Download the full report — Stonebranch 2024 Global State of IT Automation: IT Automation and Orchestration Benchmarks for IT Ops, DevOps, CloudOps, and DataOps Teams.
  • Watch the research results webinar, which highlights key trends and insights from the report, as well as Stonebranch’s recommendations for success.

About Stonebranch

Stonebranch builds IT orchestration and automation solutions that transform business IT environments from simple IT task automation into sophisticated, real-time business service automation. No matter the degree of automation, the Stonebranch platform is simple, modern, and secure. Using the Stonebranch Universal Automation Center platform, enterprises can seamlessly orchestrate workloads and data across technology ecosystems and silos. Headquartered in Atlanta, Georgia, with points of contact and support throughout the Americas, Europe, and Asia, Stonebranch serves some of the world’s largest financial, manufacturing, healthcare, travel, transportation, energy, and technology institutions.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240409835235/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping11.8.2026 07:00:00 CEST | Press release

Galderma has introduced the first-and-only shaper to the hyaluronic acid (HA) market with Restylane Shaype, now approved in the European Union (EU) for chin augmentation1 Restylane Shaype is the firmest HA gel available, powered by new NASHA HD™ technology, engineered to build and shape on bone for instant, natural-looking lower-face shaping from any angle1-3 It is the latest addition to the innovative Restylane portfolio – the world’s most diverse range of hyaluronic acid injectables designed to meet evolving aesthetic needs, backed by three decades of science4 Galderma (SIX: GALD) today announced that Restylane Shaype has been approved in the EU under the Medical Device Regulation for temporary augmentation of the chin region. Engineered for deep injection to build and shape on bone, Restylane Shaype delivers a unique bone-mimicking effect, enabling immediate, natural-looking structural enhancement in the lower face without surgery.1-3 This press release features multimedia. View the

Stonebranch is Again Named a Leader in the 2026 Gartner® Magic Quadrant™ for Service Orchestration and Automation Platforms (SOAPs)10.8.2026 17:00:00 CEST | Press release

Gartner recognizes Stonebranch as a Leader for the third consecutive year based on Completeness of Vision and Ability to Execute. Stonebranch, a leading provider of service orchestration and automation solutions, today announced that it has once again been positioned by Gartner as a Leader in the Magic Quadrant for Service Orchestration and Automation Platforms (SOAPs) for its offering, Universal Automation Center™ (UAC).1 “We’re pleased to be recognized as a Leader for the third year in a row,” said Giuseppe Damiani, CEO at Stonebranch. “To us, this recognition reflects our advancements in helping enterprises orchestrate increasingly complex IT operations with confidence. As organizations modernize their automation strategies and adopt AI, UAC provides the centralized orchestration control plane required to unify traditional automation with AI models and agentic systems. With built-in capabilities like Robi AI, UAC’s agentic copilot, we’re making it easier than ever for teams to build

Frontgrade Expands Huntsville Presence with Advanced R&D Center Supporting Next-Generation Space and Defense Missions10.8.2026 16:09:00 CEST | Press release

New facility in Cummings Research Park brings engineering closer to customers while advancing mission processing technologies and strengthening Frontgrade's long-term investment in Huntsville Frontgrade Technologies ("Frontgrade"), a leading provider of mission-critical electronics and integrated technologies, today announced the opening of its eighth U.S. location in Huntsville, Alabama. Located in Cummings Research Park, the new Advanced Research & Development Center will accelerate the development of next-generation mission processing technologies supporting critical space, defense, intelligence, and national security missions. The Huntsville center expands Frontgrade's engineering capabilities while placing research teams closer to customers, government organizations, industry partners, and leading academic institutions. By working within one of the nation's premier aerospace and defense ecosystems, Frontgrade will accelerate technology development, strengthen customer collaboratio

Brightfin Appoints Preeti Shukla as Chief Product and AI Officer10.8.2026 15:00:00 CEST | Press release

Enterprise AI SaaS leader to accelerate Brightfin's AI-Native platform for IT financial management Brightfin, the only IT Financial Management (ITFM) and Technology Expense Management solution built natively on ServiceNow, today announced the appointment of Preeti Shukla as Chief Product and AI Officer (CPAIO). In this newly created role, Shukla will lead product strategy and artificial intelligence across the Brightfin platform, advancing the company's mission to make every technology decision grounded in financial truth, operational clarity, and intelligent automation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260810283143/en/ Preeti Shukla, CPAIO of Brightfin Shukla brings two decades of experience building and scaling customer-facing, enterprise-grade B2B SaaS, fintech, and marketplace products across Fortune 100 companies and high-growth startups, including leadership roles at Workday and Oracle. A recognized autho

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration10.8.2026 12:00:00 CEST | Press release

Clinical collaboration enables novel combinations of select BeOne oncology assets with four Revolution Medicines clinical-stage RAS(ON) inhibitors for RAS-addicted cancersRegional rights agreement provides BeOne with exclusive development and commercialization rights to four Revolution Medicines clinical assets in select Asian markets BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, and Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced a multi-part collaboration including: a clinical collaboration to evaluate drug combinations incorporating select clinical-stage oncology assets from BeOne with any of Revolution Medicines’ four clinical RAS(ON) inhibitors, and a separate regional rights agreement granting BeOne exclusive development and commercialization rights to these Revolution Medicines assets in select Asian markets. Clinical

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye